Mentice AB (MNTC) - Cash Flow Conversion Efficiency
Based on the latest financial reports, Mentice AB (MNTC) has a cash flow conversion efficiency ratio of -0.086x as of September 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Skr-10.84 Million ≈ $-1.17 Million USD) by net assets (Skr125.99 Million ≈ $13.56 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Mentice AB - Cash Flow Conversion Efficiency Trend (2017–2024)
This chart illustrates how Mentice AB's cash flow conversion efficiency has evolved over time, based on yearly financial data. Read Mentice AB (MNTC) financial obligations for a breakdown of total debt and financial obligations.
Mentice AB Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Mentice AB ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
Corem Property Group AB (publ)
ST:CORE-A
|
0.015x |
|
Genoray Co. Ltd
KQ:122310
|
0.008x |
|
Covalon Technologies Ltd.
V:COV
|
-0.022x |
|
Jinli Group Holdings Ltd
TW:8429
|
0.001x |
|
Caprice Resources Ltd
AU:CRS
|
-0.023x |
|
Ihuman Inc
NYSE:IH
|
0.193x |
|
Supercom Ltd
NASDAQ:SPCB
|
-0.004x |
|
OKYO PHARMA LTD SP.ADR/65
F:OK10
|
N/A |
Annual Cash Flow Conversion Efficiency for Mentice AB (2017–2024)
The table below shows the annual cash flow conversion efficiency of Mentice AB from 2017 to 2024. For the full company profile with market capitalisation and key ratios, see MNTC company net worth.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | Skr143.66 Million ≈ $15.46 Million |
Skr17.92 Million ≈ $1.93 Million |
0.125x | -45.70% |
| 2023-12-31 | Skr158.97 Million ≈ $17.11 Million |
Skr36.52 Million ≈ $3.93 Million |
0.230x | +150.59% |
| 2022-12-31 | Skr162.63 Million ≈ $17.50 Million |
Skr14.91 Million ≈ $1.60 Million |
0.092x | +344.60% |
| 2021-12-31 | Skr136.89 Million ≈ $14.73 Million |
Skr-5.13 Million ≈ $-552.07K |
-0.037x | -120.04% |
| 2020-12-31 | Skr163.25 Million ≈ $17.57 Million |
Skr30.53 Million ≈ $3.29 Million |
0.187x | +162.59% |
| 2019-12-31 | Skr124.77 Million ≈ $13.43 Million |
Skr-37.28 Million ≈ $-4.01 Million |
-0.299x | -224.60% |
| 2018-12-31 | Skr66.74 Million ≈ $7.18 Million |
Skr16.00 Million ≈ $1.72 Million |
0.240x | -25.85% |
| 2017-12-31 | Skr48.64 Million ≈ $5.23 Million |
Skr15.73 Million ≈ $1.69 Million |
0.323x | -- |
About Mentice AB
Mentice AB (publ), together with its subsidiaries, develops, sells, and markets solutions for training and decision support in the clinical area of interventional angiography in cardiology, neurology, vascular surgery, and radiology. It operates through the Mentice VIST, Physical Sim, and Ankyras segments. The company offers virtual simulation products, including VR simulator platforms; procedura… Read more